The exact indications for computed tomography (CT) of the thorax and m
ediastinoscopy (MS) in lung cancer still remain incompletely defined.
The present study was designed to establish a standard approach to cer
vical MS for otolaryngologists, who in Denmark are traditionally invol
ved in the staging of non-small-cell lung cancer (NSCLC). Sixty-four p
otentially operable patients with NSCLC underwent thoracic CT prior to
bronchoscopy and cervical MS. Cervical MS alone established the histo
logical diagnosis in 20% of the patients. In diagnosing lymph node met
astases in the superior mediastinum, a criterion of 10 mm for abnormal
enlargement resulted in an overall sensitivity and specificity of med
iastinal CT of 81 and 84%, respectively, and the overall false-negativ
e and false-positive rates appeared to be 10 and 29%, respectively. It
could be demonstrated that mediastinal lymph nodes in patients with m
ediastinal metastases were significantly larger than mediastinal lymph
nodes in patients without metastases. No clinicopathological characte
ristics could be identified to influence the accuracy of CT, except fo
r the finding that the rate of false-negative mediastinal CT was signi
ficantly higher in patients with right-sided than in patients with lef
t-sided lesions. It is concluded that because of the relatively low se
nsitivity and specificity of mediastinal CT, cervical MS remains essen
tial in the evaluation of patients with presumed or verified NSCLC and
that cervical MS, in experienced hands, is a safe and accurate proced
ure. For Danish otolaryngologists, the strategy of routine cervical MS
, performed under general anaesthesia in the same stage as bronchoscop
y, is advocated as a standard approach to mediastinal assessment for t
he staging of NSCLC. However, thoraco-abdominal CT is advocated for al
l patients with NSCLC, in whom operation is contemplated, as a supplem
entary investigation after other routine diagnostic and staging proced
ures, including cervical MS, have been carried out.